Ngenla ( DrugBank: - )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
78下垂体前葉機能低下症2

78. 下垂体前葉機能低下症


臨床試験数 : 492 薬物数 : 341 - (DrugBank : 47) / 標的遺伝子数 : 45 - 標的パスウェイ数 : 100
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT05509894
(ClinicalTrials.gov)
November 202319/8/2022Korean Post-marketing Surveillance Ngenla® Pre-filled Pen Injection for the Treatment of Pediatric Patients With Growth Disturbance Due to Insufficient Secretion of Growth HormonePost Marketing Surveillance (PMS) Study for Ngenla® Pre-filled Pen in Pediatric Patients Who Have Growth Disturbance Due to Insufficient Secretion of Growth Hormone in KoreaPediatric Growth Hormone DeficiencyDrug: NgenlaPfizerNULLNot yet recruiting3 Years19 YearsAll565NULL
2NCT05602766
(ClinicalTrials.gov)
February 6, 202327/10/2022Ngenla Subcutaneous Injection Special InvestigationNgenla® Subcutaneous Injection Special InvestigationGrowth Hormone Deficiency Without Epiphyseal ClosureDrug: NGENLA (Somatrogon)PfizerNULLRecruitingN/A15 YearsAll229Japan